Lacto-N-triose II (LNT II) represents
a significant
neutral human milk oligosaccharide (HMO) that functions as a fundamental
structural framework for the synthesis of more complex HMOs. In this
study, we utilize GlcNAc and lactose as substrates, employing a whole-cell
catalytic approach for the synthesis of LNT II. First, we have identified
and successfully expressed three genes associated with the production
of LNT II: Nahk, EcGlmU, and LgtA, synthesized LNT II through a whole-cell
catalytic system utilizing multistrain coupling. Then, to further
enhance the yield, we incorporated yeast cells for energy regeneration,
employed coexpression strategies to minimize cell density, following
a series of systematic optimizations resulting in a 7-fold increase
in LNT II production. Finally, a two-step catalytic process was conducted
in a 5L bioreactor, and the maximum LNT II production reached 52.34
g/L with a conversion rate of lactose 95.95%.